物理学的特性を規定したナノ粒子製剤の将来性—リポソーム製剤の有用性と新規PEG修飾への展開

登录注册会员服务联系我们

物理学的特性を規定したナノ粒子製剤の将来性—リポソーム製剤の有用性と新規PEG修飾への展開—

Published:2024-01-01 Issue:1 Volume:144 Page:61-69
ISSN:0031-6903
Container-title:YAKUGAKU ZASSHI
language:en
Short-container-title:YAKUGAKU ZASSHI

Author:

Sadzuka Yasuyuki¹

Affiliation:

1. Division of Advanced Pharmaceutics, Department of Clinical Pharmaceutical Sciences, School of Pharmacy, Iwate Medical University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/yakushi/144/1/144_23-00129/_pdf

Reference24 articles.

1. 1) Ichikawa A., “Drug Delivery System,” Science of Pharmeceutics, Tokyo Kagaku Dojin, Tokyo, 2017, pp. 176–206.

2. 2) Pharmaceuticals and Medical Devices Agency. “Interview Form of Comirnaty intramuscular injection.”: 〈https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/672212_631341DA1025_1_23〉, cited 23 February, 2021.

3. 3) Pharmaceuticals and Medical Devices Agency. “Interview Form of DOXIL Injection.”: 〈https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/480348_4235402A1025_2_01〉, cited 28 January, 2011.

4. 4) Pharmaceuticals and Medical Devices Agency. “Interview Form of Onivyde I.V. Infusion.”: 〈https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/530457_4240404A3027_1_03〉, cited 19 June, 2020.

5. 5) Pharmaceuticals and Medical Devices Agency. “Interview Form of AmBisome.”: 〈https://www.pmda.go.jp/PmdaSearch/iyakuDetail/ResultDataSetPDF/400093_6173400D2023_1_16 〉, cited 25 June, 2006.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP